HYDROXYCHLOROQUINE may be the COVID-19 "blocker" of choice for US President, Donald Trump, but the State of Ohio Board of Pharmacy is less supportive of use of the anti-malarial.
From today pharmacies in Ohio will be prohibited from dispensing or selling hydroxychloroquine to treat COVID-19.
State of Ohio Board of Pharmacy Director of Policy and Communications, Cameron McNamee, said the decision had been made in the interests of patient safety.
"We're looking at the best science to determine what's best for the patients of Ohio," he said.
"The long and short of it is, we want people to focus on what works, such as social distancing and mask use.
"We ultimately want to make sure people are being safe and not exposing themselves to drugs that have shown not to be effective in treating COVID-19."
Not necessarily a man of science, Trump has noted that he's still here having taken a two-week course of the drug.
"I don't think you lose anything by doing it," he said.
"It doesn't seem to be too popular - you know why?
"Because I recommended it."
And in a move that seems to continue the US Federal Government's support for the controversial drug, camera brand Kodak has received US$765 million to pivot into producing ingredients to manufacture generic medications.
The above article was sent to subscribers in Pharmacy Daily's issue from 30 Jul 20
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 30 Jul 20
